Medical Developments International Limited (FRA:M5D)

Market Cap	25.83M -41.5%
Revenue (ttm)	25.78M +9.0%
Net Income	379.07K +566.0%
EPS	0.00 +562.4%
Shares Out	n/a
PE Ratio	61.44
Forward PE	29.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	650
Open	0.2040
Previous Close	0.2040
Day's Range	0.2040 - 0.2040
52-Week Range	0.0100 - 0.3180
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 18, 2026

About FRA:M5D

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M5D

Financial Performance

In fiscal year 2026, FRA:M5D's revenue was 42.57 million, an increase of 8.99% compared to the previous year's 39.06 million. Earnings were 626,000, an increase of 565.96%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error